BIOMAT Database Logo BIOMAT Database Logo

New insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppression. 2010

Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
Molecular Immunology and Inflammation Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA. stewardtharpsm@mail.nih.gov

T cell-directed therapies have become mainstays in the management of various autoimmune diseases and organ transplantation. The understanding of T cell biology has expanded greatly since the development of most agents currently in use. Here we discuss important recent discoveries pertaining to T helper cell differentiation, lineage commitment, and function. Within this context, we examine existing T cell-directed therapies, including new agents being evaluated in clinical and preclinical studies. We also use recent findings to speculate on novel targets.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001327 Autoimmune Diseases Disorders that are characterized by the production of antibodies that react with host tissues or immune effector cells that are autoreactive to endogenous peptides. Autoimmune Disease,Disease, Autoimmune,Diseases, Autoimmune
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D015551 Autoimmunity Process whereby the immune system reacts against the body's own tissues. Autoimmunity may produce or be caused by AUTOIMMUNE DISEASES. Autoimmune Response,Autoimmune Responses,Autoimmunities
D016503 Drug Delivery Systems Systems for the delivery of drugs to target sites of pharmacological actions. Technologies employed include those concerning drug preparation, route of administration, site targeting, metabolism, and toxicity. Drug Targeting,Delivery System, Drug,Delivery Systems, Drug,Drug Delivery System,Drug Targetings,System, Drug Delivery,Systems, Drug Delivery,Targeting, Drug,Targetings, Drug

Related Publications

Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
New insights into chronic inflammation-induced immunosuppression.
August 2012, Seminars in cancer biology,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
Molecular biology of autoantigens and new insights into autoimmunity.
April 1993, The Clinical investigator,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
The spectrum of cutaneous T-cell lymphomas: new insights into biology and therapy.
July 2005, Current opinion in hematology,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.
May 2006, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
[New insights into adipose cell biology].
January 2013, Bulletin de l'Academie nationale de medecine,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
[New insights into adipose cell biology].
March 2004, Annales pharmaceutiques francaises,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
Lymphocytic leukemias: new insights into biology and therapy.
November 1992, Leukemia,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
Tumor and T-cell metabolism: new insights into melanoma therapy.
April 2016, Clinical advances in hematology & oncology : H&O,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
The new reagent therefore reveals roles for CD4+LAP+ T cells in immunosuppression, inflammation and autoimmunity.
February 2015, International immunology,
Scott M Steward-Tharp, and Yun-jeong Song, and Richard M Siegel, and John J O'Shea
Chronic lymphocytic leukemia: new insights into biology and therapy.
October 1990, Annals of internal medicine,
Copied contents to your clipboard!